
Monday, June 09, 2025 7:40:22 AM
I've been here for over 15 years. And yes I'm as ready as anyone else for this to start moving. I'm over your example of 70 and have no intention of selling way prematurely.
Yes I'm ready to move when the prices increase, but no I won't sell for a fraction of the true value just to be out. We have never been this close to success in our history. Never have we had a large inventory of raw material ready to be spun with people with known industry names waiting and willing to buy it. Never before have we been to this level of success.
So... if youre sincere in your remarks and have sold all good luck to you, but if your like a vulture wanting to discourage the older stockholders to selling shares at distress prices so you can scoop them .... go to hell!
Recent KBLB News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/29/2025 09:10:15 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2025 08:30:48 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/06/2025 08:30:48 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/30/2025 04:15:09 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/29/2025 11:37:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/17/2025 09:00:55 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/17/2025 09:00:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2025 08:44:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/08/2025 09:09:11 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/28/2025 08:46:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2025 08:30:35 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/14/2025 05:11:50 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 02/13/2025 10:21:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/21/2025 10:14:03 PM
- Form AW - Amendment Withdrawal Request • Edgar (US Regulatory) • 12/19/2024 09:30:04 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/19/2024 09:05:37 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2024 09:30:40 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/16/2024 09:00:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:30:52 PM
Fifty1 AI Labs' REVIVE Clinical Trial Redefines Long COVID Treatment, Pioneering AI-Driven Therapies and Propelling Fifty 1 Labs, Inc. Toward $50M Valuation and Global Biotech Leadership • FITY • Jul 10, 2025 8:30 AM
Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • ASBP • Jul 9, 2025 9:15 AM
Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM
Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM
Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM